Goodfellow supplies metals, ceramics and other materials to meet the research, development and specialist production requirements of science and industry worldwide.
The Goodfellow group consists of...
CiDRA Precision Service's customer base covers a wide breadth of companies in size and technologies, from well established Fortune 500 companies thru to struggling start-ups. Regardless of the...
News - 24 Jun 2022
In a review recently published in the journal Bioprinting, researchers presented a comprehensive review of the development of cardiac tissue using cardiovascular 3D bioprinting.
News - 18 Aug 2021
A biodegradable and customizable 3D printed vascular graft could help prevent heart failure in cardiovascular patients.
Image Credit: Juan Domínguez-Robles, Tingjun Shen, Victoria A. Cornelius,...
News - 3 Aug 2021
The use of a conductive nanomaterial-based cardiac tissue engineering system could help patients recover from heart attacks.
Image Credit: Shutterstock.com / Theerani lerdsri
News - 10 Nov 2014
Experts will unveil a new 3D-printed model of the heart at EuroEcho-Imaging 2014, the official European Association of Cardiovascular Imaging (EACVI) annual meeting that is set to take place at the...
News - 4 Jun 2009
Scientists and engineers at UC Santa Barbara and other researchers have developed a nanoparticle that can attack plaque - a major cause of cardiovascular disease. The new development is described in a...
News - 5 Mar 2009
Scientists of the national German metrology institute, the Physikalisch-Technische Bundesanstalt (PTB), have developed a highly sensitive measuring method with which the efficiency of gene transfer in...
News - 23 Feb 2009
Medtronic, Inc. (NYSE: MDT) announced today it has signed a definitive agreement to acquire CoreValve, Inc., developer of a transcatheter, transfemoral aortic valve replacement product. This...
Article - 7 Jun 2010
DSM have recently introduced a new grade of Dyneema Purity ultrahigh molecular weight polyethylene (UHMWPE) film for cardiovascular applications. AZoM conducted this interview with DSM to find out...